Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00254787 | Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients | PHASE2 | COMPLETED | 30 | — | — | Jun 1, 2005 | Jan 1, 2006 | Jun 11, 2009 | 6 | Germany |
| Name | Type | Description |
|---|---|---|
| IR (Immediate-Release) quetiapine fumarate (drug) | DRUG | - |
Inclusion Criteria: * Men and women age ≥18 to ≤65 years with acute schizophrenia * Provision of written informed consent prior to enrolment Exclusion Criteria: * Meeting the criteria for any other (than schizophrenia) psychotic disorder not in full remission, concomitant organic mental disorder ...